Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

JAK2 V617F

Clinical trials for JAK2 V617F explained in plain language.

Never miss a new study

Get alerted when new JAK2 V617F trials appear

Sign up with your email to follow new studies for JAK2 V617F, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1
Sort by
  • Could new blood thinners outperform aspirin for clot prevention in MPN patients?

    Prevention Recruiting now

    This study compares two newer blood thinners (apixaban and rivaroxaban) against daily low-dose aspirin to prevent dangerous blood clots in people with JAK2-positive myeloproliferative neoplasms (MPNs), a group of chronic blood cancers. About 1,300 high-risk adults (over 60 or wit…

    Matched conditions: JAK2 V617F

    Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Prevention

    Last updated May 20, 2026 11:55 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space